{"metadata":{"topics":["Abstention","Accountability","Accounting","Administrative law","Adoption","Alexion Pharmaceuticals","Amortization (business)","Analysis","Applied ethics","Asset","Asset forfeiture","Audit","Balance sheet","Behavioural sciences","Beneficiary","Board of directors","Book value","Business","Business economics","Business law","Business organizations","Capital (economics)","Cash","Cash flow","Certainty","Change","Civil law (common law)","Civil law (legal system)","Clinical trial","Cognition","Cognitive science","Committee","Common law","Common stock","Companies","Company","Comparative law","Conflict of laws","Consent","Consolidation (business)","Construction","Consultant","Contract","Contract law","Corporate finance","Corporate governance","Corporate jargon","Corporate law","Corporate personhood","Corporate spin-off","Corporation","Corporations","Corporatism","Cost","Covenant (law)","Culture","Customer","Customer satisfaction","Customs","Debt","Deferral","Deferred compensation","Definition","Delaware","Delaware General Corporation Law","Deliverable","Depreciation","Derivatives (finance)","Disability","Divestment","Dividend","Document","Economic law","Economics","Economies","Economy","Economy of the United States","Employee benefits","Employee relations","Employee stock option","Employment","Employment compensation","Environmental law","Equity (finance)","Equity (law)","Equity securities","Ethical principles","Ethics","Executive compensation","Executive officer","Exercise","Existence","Expense","Factor income distribution","Fair market value","Fair value","Family economics","Fee","Fiduciary","Finance","Financial accounting","Financial economics","Financial law","Financial markets","Financial services","Financial statement","Financial statements","Fiscal year","Free cash flow","Fundamental analysis","Fungibility","Goal","Good faith","Governance","Government","Government agencies","Government finances","Government information","Government of the United States","Gross domestic product","Gross income","Household income","Human activities","Incentive","Incentive stock option","Income","Income statement","Indemnity","Independent contractor","Index (economics)","Information","Information technology","Instrumental and intrinsic value","Intellectual works","Interest","Internal Revenue Code","Internal Revenue Code section 409A","Internal Revenue Service","International law","Interpersonal relationships","Intrinsic value (finance)","Investment","Investment fund","Jargon","Job satisfaction","Joint venture","Judicial disqualification","Jurisdiction","Justice","Labor","Law","Law and economics","Law of obligations","Law of the United States","Lawsuit","Leadership","Leave of absence","Legal concepts","Legal documents","Legal ethics","Legal fictions","Legal liability","Legal person","Legal writing","Liability (financial accounting)","License","Lien","Limited liability","Limited liability company","Liquidation","Macroeconomics","Management","Manufacturing","Market (economics)","Market penetration","Market trends","Market value","Matter","Measurement","Mergers and acquisitions","Microeconomics","Money","Moneyness","Morality","NASDAQ","Natural resources law","Nature","Net income","New product development","Nothing","Number","Open government","Operating margin","Option (finance)","Options (finance)","Organization","Organizational behavior","Ownership","Parliamentary procedure","Partnership","Patent","Patent application","Payment","Payments","Payroll","Percentage","Personal finance","Personality traits","Philosophical theories","Philosophy","Political economy","Political ideologies","Political law","Political science","Politics","Price","Principles","Private law","Profit (accounting)","Profit margin","Property","Property law","Proxy voting","Psychology","Public administration","Public finance","Public law","Public policy","Public sphere","Quorum","Rate of return","Reason","Regulation","Regulatory compliance","Restricted stock","Retirement","Return on capital","Return on equity","Return on investment","Revenue","Rights","Risk","Risk management","Roman law","Rules","Securities (finance)","Securities Act of 1933","Securities Exchange Act of 1934","Security (finance)","Service industries","Services (economics)","Severability","Severe acute respiratory syndrome","Share (finance)","Share price","Shareholder","Social institutions","Social issues","Sociological theories","Stock","Stock appreciation right","Stock exchange","Stock market","Stock split","Strategic management","Subsidiary","Suffrage","Tax","Tax deduction","Taxation","Technology","Termination of employment","Time","Treasury stock","Trial","Trust law","Trustee","U.S. Securities and Exchange Commission","U.S. state","United States","United States dollar","United States economic policy","United States federal policy","Urban, rural, and regional economics","Valuation (finance)","Value (economics)","Value (ethics)","Value added","Vesting","Virtue","Wage","Warrant (finance)","Warranty","Withholding tax","Working conditions"],"person_names":["sar"],"vars":{"Party":{"incorporated":"[[Party 1]]"}},"organization_names":["alexion pharmaceuticals, inc.","control","eligible person","nasdaq","participant","treas","treasury regulation"],"agreement_id":"f3a4bd1d2376c9aa29f5a9b4cbdd5367631c3b0c853c6ac1b36af5646f41f5e0","terms":["**ALEXION PHARMACEUTICALS, INC.**","**AMENDED AND RESTATED 2004 INCENTIVE PLAN**","*409A*","*409A.*","*Adjustments*","*Administration*","*Annual Incentive Awards Granted to Designated Covered Employees*","*Authority of the Committee*","*Award and Restrictions*","*Awards to Participants Outside the United States*","*Bonus Stock and Awards in Lieu of Obligations*","*Business Criteria*","*Certain Provisions Applicable to Awards*","*Certificates for Stock*","*Change in Control.*","*Changes to the Plan*","*Compliance with Code Section 162(m)*","*Compliance with Legal and Other Requirements*","*Deferred Stock*","*Definition of “Change in Control.”*","*Definitions*","*Dividend Equivalents*","*Dividends and Splits*","*Effect of “Change in Control” on Outstanding Awards*","*Eligibility and Certain Award Limitations*","*Eligibility.*","*Exemptions from Section 16(b) Liability*","*Exercise Price*","*Forfeiture*","*Form and Timing of Payment under Awards; Deferrals*","*Fungible Share Pool*","*General Provisions.*","*General*","*Governing Law*","*Grant and Restrictions*","*Grant of Annual Incentive Awards*","*Limitation of Liability*","*Limitation on Rights Conferred under Plan*","*Limitation on Vesting of Certain Awards*","*Limits on Transferability; Beneficiaries*","*Manner of Exercise of Committee Authority*","*Nonexclusivity of the Plan*","*Option Term; Time and Method of Exercise*","*Options*","*Other Stock-Based Awards*","*Other Terms*","*Overall Number of Shares Available for Delivery*","*Payments in the Event of Forfeitures; Fractional Shares*","*Payout of Annual Incentive Awards*","*Per-Person Award Limitations.*","*Performance Award Pool*","*Performance Awards Generally*","*Performance Awards Granted to Covered Employees*","*Performance Awards*","*Performance Awards, including Annual Incentive Awards*","*Performance Goal Generally*","*Performance Period; Timing for Establishing Performance Goals*","*Plan Effective Date and Termination*","*Purpose*","*Required Consent to and Notification of Code Section 83(b) Election*","*Restricted Stock*","*Right of Setoff*","*Right to Payment*","*Settlement of Performance Awards; Other Terms*","*Severability; Entire Agreement*","*Share Counting Rules*","*Share Counting*","*Specific Terms of Awards*","*Stand-Alone, Additional, Tandem, and Substitute Awards*","*Stock Appreciation Rights*","*Stock Subject to Plan*","*Term of Awards*","*Unfunded Status of Awards; Creation of Trusts*","*Withholding*","*Written Determinations*","*et seq.*","“Company”","“Effective Date”","“Plan”","“Significant Subsidiary”"]}}